# EDGAR Filing Document

**Accession Number:** 0001783032
**File Stem:** 0001104659-25-057622
**Filing Date:** 2025-6
**Character Count:** 3247
**Document Hash:** 1501c8fad403ed1f4f1e35b374397e0b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-057622.hdr.sgml**: 20250609

**ACCESSION NUMBER**: 0001104659-25-057622

**CONFORMED SUBMISSION TYPE**: SC14D9C

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250609

**DATE AS OF CHANGE**: 20250609

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Elevation Oncology, Inc.
- **CENTRAL INDEX KEY:** 0001783032
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 841771427
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC14D9C
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-92657
- **FILM NUMBER:** 251032876

**BUSINESS ADDRESS:**
- **STREET 1:** 101 FEDERAL STREET
- **STREET 2:** SUITE 1900
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02110
- **BUSINESS PHONE:** 7163711125

**MAIL ADDRESS:**
- **STREET 1:** 101 FEDERAL STREET
- **STREET 2:** SUITE 1900
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02110

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** 14ner Oncology, Inc.
- **DATE OF NAME CHANGE:** 20190719
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Elevation Oncology, Inc.
- **CENTRAL INDEX KEY:** 0001783032
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 841771427
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC14D9C

**BUSINESS ADDRESS:**
- **STREET 1:** 101 FEDERAL STREET
- **STREET 2:** SUITE 1900
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02110
- **BUSINESS PHONE:** 7163711125

**MAIL ADDRESS:**
- **STREET 1:** 101 FEDERAL STREET
- **STREET 2:** SUITE 1900
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02110

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** 14ner Oncology, Inc.
- **DATE OF NAME CHANGE:** 20190719

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**SCHEDULE 14D-9**

**SOLICITATION/RECOMMENDATION STATEMENT**

**UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934**

**Elevation Oncology, Inc.**

**(Name of Subject Company)**

**Elevation Oncology, Inc.**

**(Name of Persons Filing Statement)**

**COMMON STOCK, PAR VALUE $0.0001 PER SHARE**

**(Title of Class of Securities)**

**<u>28623U101</u>**

**(CUSIP Number of Class of Securities)**

**Tammy Furlong**

**101 Federal Street, Suite 1900**

**Boston, Massachusetts**

**(716) 371-1135**

 ****

***With copies to:***

**Robert Freedman , Esq.**

**David Michaels, Esq.**

**Ryan Mitteness, Esq.**

**Fenwick and West LLP**

**401 Union Street, Floor 5**

**Seattle, WA**

**(206) 389-4510** 

**(Name, address, and telephone numbers of person authorized to receive notices and communications**

**on behalf of the persons filing statement)**

x Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

The information set forth under Items 1.01, 5.02, 5.07, 7.01 and 9.01 of the Current Report on Form 8-K filed by Elevation Oncology, Inc. on June 9, 2025 (including all exhibits attached thereto) is incorporated herein by reference.